This article is more than 5 years old. Information may no longer be current.

DSM launches new cellular therapy services

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

DSM has announced the launch of its new autologous cellular therapy development service.

The company plans to work directly with biotechnology and medical device companies to aid in their use of this type of therapy, which incorporates a patient’s own cells to promote healing, according to a company press release.

The first cell concentration device, developed by DSM and launched by DePuy Synthes Mitek Sports Medicine, is the PEAK Platelet Rich Plasma System.

This device is able to extract a high concentration of undamaged platelets from whole blood in approximately two and a half minutes, according to the release. Additionally, the device weighs only 4 pounds, allowing for ease of transport through hospitals or doctors’ offices.